Navigating Schizophrenia Part 3: The Role of Long-Acting Injectable Antipsychotics in the Treatment Journey - A Patient Perspective

Navigating Schizophrenia Part 3: The Role of Long-Acting Injectable Antipsychotics in the Treatment Journey - A Patient Perspective

The goal of this activity is to improve clinician and patient/caregiver understanding of the benefits of use of LAI antipsychotic therapies for treatment of schizophrenia.

  • Provider:Medscape, LLC
  • Activity Link: https://www.medscape.org/viewarticle/1001968
  • Start Date: 2024-12-11 06:00:00
  • End Date: 2024-12-11 06:00:00
  • Credit Details: AMA PRA Category 1 Credit™️: 0.5 hours
    Nursing: 0.5 hours
  • Commercial Support: Source: Janssen (Any division) - Amount: 59616.0 - Is Kind Support: False
  • Activity Type: Other/Blended Learning
  • CME Finder Type: Other
  • Fee to Participate: No, it's free
  • Measured Outcome: Learner Knowledge, Learner/Team Competence
  • Provider Ship: Directly Provided
  • Registration: Open to all
«
»
Subscribe
Notify of
guest
0 Comments
Oldest
Newest Most Voted
Inline Feedbacks
View all comments
0
Would love your thoughts, please comment.x
()
x

Contact us

If you want to join leaders who will shape what Americans think about sleep.

Name(Required)
Sign Up
This field is for validation purposes and should be left unchanged.

Sign up for the expert list

for media inquiries

Name(Required)
Sign Up
This field is for validation purposes and should be left unchanged.